C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
530/15.06
C07K 14/475 (2006.01) C07K 14/52 (2006.01) A61K 38/00 (2006.01) G01N 30/02 (2006.01)
Patent
CA 2003350
HUMAN NEUTROPHILIC GRANULOCYTE END-STAGE MATURATION FACTOR AND ITS PREPARATION AND USE ABSTRACT OF THE DISCLOSURE The end-stage maturation of neutrophilic granulocyte precursor cells isolated from normal human bone marrow by Ficoll density centrifugation was studied in a liquid culture assay system used previously to study the maturation of guinea pig granulocyte precursors. Dialyzed normal human serum induced end-stage morphological maturation of human granulocyte precursors and this induction was proportional to a serum level of up to 5.0% in the assay medium. At serum concentrations greater than 5.0% a pronounced inhibition of maturation was observed. Passage of serum through a DEAE-Fractogel 650S column equilibrated with 0.01M phosphate buffer (pH 7.0) resulted in the binding of the end-stage granulocyte maturation factor (GMF) to the column. The activity eluted from the column in a fraction containing 17% of the starting serum protein that was inhibitor-free and was also capable of inducing the appearance of granulocyte alkaline phosphates, a specific biochemical marker for granulocyte end-stage maturation. GMF is most likely a protein since it was destroyed by protease digestion. The data also indicate that neither purified human transferrin nor human recombinant granulocyte colony-stimulating factor can substitute for human serum GMF as a granulocyte end-stage maturation factor in this assay system. It was observed, however, that purified human transferrin greatly potentiated the effect of GMF suggesting that transferrin plays a supporting role in the end stage maturation of human granulocytes in vitro. Taken together the evidence presented here strongly supports the existence of a previously undescribed neutrophilic granulocyte end-stage maturation factor in normal human serum,
Evans Warren H.
Wilson Shirley M.
Evans Warren H.
Gowling Lafleur Henderson Llp
U.s. Department Of Commerce United States Of America Represented By The Secretary
Wilson Shirley M.
LandOfFree
Human neutrophilic granulocyte end-stage maturation factor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human neutrophilic granulocyte end-stage maturation factor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human neutrophilic granulocyte end-stage maturation factor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1535558